Skip to main content

real-world evidence

Consensus Statements
12/18/2024
The panel discussions aimed to foster the development and availability of innovative and effective wound-healing therapies to drive advancements and outcomes. The proceedings of the Summit discussion are presented here as expert consensus...
The panel discussions aimed to foster the development and availability of innovative and effective wound-healing therapies to drive advancements and outcomes. The proceedings of the Summit discussion are presented here as expert consensus...
The panel discussions aimed to...
12/18/2024
Wounds
Editorial Message
11/01/2022
Dr. John C. Lantis II, Clinical Editor, considers the importance of--and difficulty in collecting--real-world data related to patients outcomes.
Dr. John C. Lantis II, Clinical Editor, considers the importance of--and difficulty in collecting--real-world data related to patients outcomes.
Dr. John C. Lantis II, Clinical...
11/01/2022
Wounds
Guest Editorial
04/01/2022
Now is a unique time for clinicians to articulate the realities and complexities of wound care.
Now is a unique time for clinicians to articulate the realities and complexities of wound care.
Now is a unique time for...
04/01/2022
Wound Management & Prevention
Real-World Treatment Patterns, Survival Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Videos
02/25/2021
Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men with metastatic castration-resistant prostate cancer who initiated ADT or ADT combined with anti-androgens, docetaxel, or abiraterone.
Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men with metastatic castration-resistant prostate cancer who initiated ADT or ADT combined with anti-androgens, docetaxel, or abiraterone.
Stephen Freedland, MD, discusses...
02/25/2021
Journal of Clinical Pathways
Study Finds No Correlation Between Antibiotic Use and OS in Metastatic Urothelial Carcinoma
Videos
02/19/2021
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors on overall survival among patients with metastatic urothelial carcinoma in real-world practice.
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors on overall survival among patients with metastatic urothelial carcinoma in real-world practice.
Shilpa Gupta, MD, discusses the...
02/19/2021
Journal of Clinical Pathways
Conference Coverage
02/15/2021
Journal of Clinical Pathways
Real-World Biomarker Testing, Treatment Patterns in CLL/SLL
Videos
12/17/2020
Anthony Mato, MD, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with CLL in the clinical practice setting, using the informCLL prospective registry.
Anthony Mato, MD, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with CLL in the clinical practice setting, using the informCLL prospective registry.
Anthony Mato, MD, discusses...
12/17/2020
Journal of Clinical Pathways